ECO ANIMAL HEALTH GROUP PLC

Director's Dealing • Aug 30, 2024

National Storage Mechanism | Additional information

RNS Number : 3786C

Eco Animal Health Group PLC

30 August 2024

30 August 2024

ECO Animal Health Group plc

("ECO" or the "Company")

Director/PDMR Dealings

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has been notified that on 30 August 2024, David Hallas, Chief Executive Officer, purchased 18,181 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 110 pence per share.

Following this transaction, David Hallas' total interest in the Company is 109,334 Ordinary Shares, representing approximately 0.16 per cent. of the Company's issued share capital.

Details of the transactions can be found in the Notification of Dealing Form below.

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher	020 7496 3000
Investec (Joint Broker) Gary Clarence Lydia Zychowska	020 7597 5970
Equity Development Hannah Crowe Matt Evans	020 7065 2692
ICR Consilium (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700 ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Hallas
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	ECO Animal Health Group plc
b)	LEI	2138009XN9DJ3YP70B55
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 5 pence each
Identification code	GB0032036807
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		110 pence	18,181
d)	Aggregated information	N/A - Single transaction
- Aggregated volume
- Price
e)	Date of the transaction	30 August 2024
f)	Place of the transaction	London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSGDILGXDGSG